|
HY-132042-50mg
|
MedChemexpress LLC
|
Bromo-PEG2-MS [CAS 1935075-34-5]
|
|
Cancer-programmed cell death
|
|
|
HY-132024-100mg
|
MedChemexpress LLC
|
Bromo-PEG4-MS [CAS 2167807-41-0]
|
|
Cancer-programmed cell death
|
|
|
HY-132024-250mg
|
MedChemexpress LLC
|
Bromo-PEG4-MS [CAS 2167807-41-0]
|
|
Cancer-programmed cell death
|
|
|
HY-132024-50mg
|
MedChemexpress LLC
|
Bromo-PEG4-MS [CAS 2167807-41-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W096069-10mg
|
MedChemexpress LLC
|
Hydroxy-PEG3-MS [CAS 139115-89-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W096069-25mg
|
MedChemexpress LLC
|
Hydroxy-PEG3-MS [CAS 139115-89-2]
|
|
Cancer-programmed cell death
|
|
|
HY-103663-10mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
|
HY-103663-100mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
|
HY-103663-25mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
|
HY-103663-5mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
|
HY-103663-50mg
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4]
|
|
Cancer-programmed cell death
|
|
|
HY-103663-1mL
|
MedChemexpress LLC
|
MAK683 [CAS 1951408-58-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-130457-100mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
|
HY-130457-250mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
|
HY-130457-50mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
